A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
Key facts
- Study ID
- NCT07122986
- Run by
- Pfizer
- People needed
- 310
- Starts
- 2025-08-11
- Expected to finish
- 2028-05-26
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
Where it is running
- Anaheim Clinical Trials, LLC — Anaheim, California, United States (enrolling)
- Orange County Research Center — Lake Forest, California, United States (enrolling)
- Diablo Clinical Research, Inc. — Walnut Creek, California, United States (enrolling)
- Miami Eye Institute — Hollywood, Florida, United States (enrolling)
- Research Centers of America — Hollywood, Florida, United States (enrolling)
- NYU Langone Health — New York, New York, United States (enrolling)
- CTI Clinical Research Center — Cincinnati, Ohio, United States (enrolling)
- Senders Pediatrics — South Euclid, Ohio, United States (enrolling)
- Alliance for Multispecialty Research, LLC — Knoxville, Tennessee, United States (enrolling)
- Alliance for Multispecialty Research, LLC — Knoxville, Tennessee, United States (enrolling)
- University Eye Specialists, P.C. (Ophthalmologist) — Maryville, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.